Price
CHART BY
Frequently asked questions
What is BioVie's market capitalization?
The market capitalization of BioVie is $33.76M. Market capitalization is a measure of the total market value of a publicly traded company. It is calculated by multiplying the current stock price by the total number of outstanding shares.
What is the Earnings Per Share (EPS) for BioVie?
BioVie's Earnings Per Share (EPS) over the trailing twelve months (TTM) is -$5.698. EPS indicates the company's profitability on a per-share basis.
What are the analyst ratings and target price for BioVie's stock?
Currently, 1 analysts cover BioVie's stock, with a consensus target price of $5.00. Analyst ratings provide insights into the stock's expected performance.
What is the EBITDA for BioVie?
BioVie's Earnings before interest, taxes, depreciation, and amortization (EBITDA) over the trailing twelve months is -$25.20M. EBITDA measures the company's overall financial performance.
What is the free cash flow of BioVie?
BioVie has a free cash flow of -$19.35M. Free cash flow indicates the cash generated after accounting for cash outflows to support operations and capital assets.
How many employees does BioVie have, and what sector and industry does it belong to?
BioVie employs approximately 14 people. It operates in the Health Care sector, specifically within the Biotechnology industry.
What is the free float of BioVie's shares?
The free float of BioVie is 15.36M. Free float refers to the number of shares available for public trading, excluding restricted shares.
Financials
- Market Cap
- $33.76M
- EPS (TTM)
- -$5.698
- Free Float
- 15.36M
- EBITDA (TTM)
- -$25.20M
- Free Cashflow (TTM)
- -$19.35M
Pricing
- 52W span
- $0.262$7.50
Analyst Ratings
The price target is $5.00 and the stock is covered by 1 analysts.
Buy
1
Hold
0
Sell
0
Information
BioVie, Inc. is a biopharmaceutical company, which engages in discovery, development, and marketing drug therapies for neurological and neurodegenerative disorders and liver disease. The company was founded on April 10, 2013 and is headquartered in Carson City, NV.
- Employees
- 14
- Industries
- Biotechnology
- Sector
- Health Care
Identifier
- ISIN
- US09074F4054
- Primary Ticker
- BIVI